跳至主要内容
临床试验/ISRCTN91141124
ISRCTN91141124进行中(未招募)3 期

Premature Ovarian Insufficiency Study of Effectiveness of hormonal therapy

niversity College London0 个研究点目标入组 480 人开始时间: 2021年9月9日最近更新:
适应症

试验速览

阶段
3 期
状态
进行中(未招募)
发起方
入组人数
480

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • Current inclusion criteria as of 03/01/2024:
  • 1. Diagnosis of POI (based on NICE guidelines) or with an established diagnosis of POI (e.g. Turner Syndrome, surgical menopause)
  • 2. Will be aged older than 18 and less than 40 years at randomisation
  • 3. Not intending to become pregnant within 12 months
  • 4. Not taken any HRT, COC or testosterone treatment for the last 4 weeks or willing to stop HRT/COC/testosterone treatment for a minimum period of 4 weeks prior to randomisation
  • 5. Must provide written/electronic informed consent
  • Previous inclusion criteria:
  • 1. Diagnosis of POI
  • 2. Will be aged older than 18 and less than 40 years at randomisation
  • 3. Not intending to become pregnant within 12 months
  • 4. Not taken any HRT or COC treatment for the last 4 weeks or willing to stop HRT/COC treatment for a minimum period of 4 weeks prior to randomisation
  • 5. Must provide written/electronic informed consent

排除标准

  • Current exclusion criteria as of 03/01/2024:
  • 1. Contraindications to HRT or COC
  • 2. Taking other drugs affecting BMD e.g. bisphosphonates and long-term use of systemic corticosteroids (dietary supplements e.g. Vitamin D, calcium and short course of corticosteroids are permitted)
  • 3. Receiving estrogens for puberty induction
  • 4. Participation in a clinical research study (currently or in the last 3 months) involving testosterone treatments or novel HRT formulations
  • Previous exclusion criteria:
  • 1. Contraindications to HRT or COC
  • 2. Taking other drugs affecting BMD e.g. bisphosphonates and long-term use of systemic corticosteroids (dietary supplements e.g. Vitamin D, calcium and short course of corticosteroids are permitted)
  • 3. Receiving sex steroid hormones for puberty induction
  • 4. Participation in a clinical research study (currently or in the last 3 months) involving testosterone treatments or novel HRT formulations

研究者

发起方
niversity College London

相似试验